BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33158297)

  • 1. Tamoxifen Delivery System Based on PEGylated Magnetic MCM-41 Silica.
    Popova M; Koseva N; Trendafilova I; Lazarova H; Mitova V; Mihály J; Momekova D; Momekov G; Koleva IZ; Aleksandrov HA; Vayssilov GN; Szegedi Á
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33158297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers.
    Wang Y; Han N; Zhao Q; Bai L; Li J; Jiang T; Wang S
    Eur J Pharm Sci; 2015 May; 72():12-20. PubMed ID: 25701727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
    Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of host-guest system to enhance the tamoxifen efficiency.
    Heidari Majd M; Akbarzadeh A; Sargazi A
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):441-447. PubMed ID: 27012732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
    Popova M; Mihaylova R; Momekov G; Momekova D; Lazarova H; Trendafilova I; Mitova V; Koseva N; Mihályi J; Shestakova P; St Petkov P; Aleksandrov HA; Vayssilov GN; Konstantinov S; Szegedi Á
    Eur J Pharm Biopharm; 2019 Sep; 142():460-472. PubMed ID: 31336182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartic acid functionalized PEGylated MSN@GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery.
    Rahmatolahzadeh R; Hamadanian M; Ma'mani L; Shafiee A
    Adv Med Sci; 2018 Sep; 63(2):257-264. PubMed ID: 29486375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
    Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
    Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
    Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
    Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
    Qiu XL; Li QL; Zhou Y; Jin XY; Qi AD; Yang YW
    Chem Commun (Camb); 2015 Mar; 51(20):4237-40. PubMed ID: 25670321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
    Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
    Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
    Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
    J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
    Thakur CK; Thotakura N; Kumar R; Kumar P; Singh B; Chitkara D; Raza K
    Int J Biol Macromol; 2016 Dec; 93(Pt A):381-389. PubMed ID: 27586640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.